Company profile for Waverley Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Waverley Pharma Inc. is a specialty pharma company that is dedicated to the development and commercialization of safe, effective and affordable therapeutics. The company’s current focus is on the generic oncology market in the United Kingdom (U.K.) and North America. The company has three oncology generic products on the U.K. market, and is awaiting regulatory approval of two additional oncology generics for the U.K. and Nor...
Waverley Pharma Inc. is a specialty pharma company that is dedicated to the development and commercialization of safe, effective and affordable therapeutics. The company’s current focus is on the generic oncology market in the United Kingdom (U.K.) and North America. The company has three oncology generic products on the U.K. market, and is awaiting regulatory approval of two additional oncology generics for the U.K. and North American markets. The company is currently developing a pipeline of products in different stages of development, through multiple partnerships.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
4-1250 Waverley Street Winnipeg, Manitoba R3T 6C6
Telephone
Telephone
(204) 928-7907
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211898

FDA
11 Oct 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211899

FDA
25 May 2022

https://www.newswire.ca/news-releases/waverley-pharma-announces-successful-tender-award-for-pemetrexed-with-nhs-england-869942373.html#:~:text=(%22Waverley%20Pharma%22%20or%20the,the%20National%20Health%20Service%20of

NEWSWIRE
27 May 2021

https://www.newswire.ca/news-releases/waverley-pharma-announces-successful-tender-award-for-capecitabine-with-nhs-scotland-873931838.html#:~:text=Waverley%20Pharma%20Inc.&text=This%20opportunity%20also%20represents%20WPEL's,a%20duration%20of%20two%20years.

NEWSWIRE
18 Jan 2021

https://www.newswire.ca/news-releases/waverley-pharma-announces-signing-of-term-sheet-to-acquire-exclusive-rights-to-market-six-generic-oncology-products-in-the-united-states-863075454.html#:~:text=(%22Waverley%20Pharma%22%20or%20the,the%20Company%20the%20exclusive%20right

NEWSWIRE
09 Sep 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty